Home・Aktien・Quanterix Corp

Quanterix Corp

Geschlossen

BrancheGesundheitswesen

2.63 -1.13

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.66

Max

2.7800000000000002

Schlüsselkennzahlen
By Trading Economics
Einkommen	-31M -49M
Verkäufe	-3.5M 33M
EPS	-0.45
Gewinnspanne	-148.708
Angestellte	450
EBITDA	-38M -49M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	+7.53% upside

Dividenden
By Acuity
Nächstes Ergebnis	9. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	18M 132M
Vorheriger Eröffnungskurs	3.76
Vorheriger Schlusskurs	2.63

Nachrichtenstimmung

By Acuity

50%

160 / 340 Ranking in Healthcare

Quanterix Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

24. Aug. 2026, 20:02 UTC

Quanterix Corp shares are lower today, continuing a decline that began Friday. The stock is near the lower end of its one-month range.

22. Aug. 2026, 00:02 UTC

Quanterix Corp shares are lower in after-market trading, continuing a decline since Friday's close, with no specific news identified for the movement.

20. Aug. 2026, 20:06 UTC

Quanterix Corp shares are higher today amid increased market activity. The stock's movement aligns with broader trends, including rising U.S. Treasury yields and crude oil prices.

19. Aug. 2026, 22:31 UTC

Quanterix Corp shares are higher in after-market trading, reflecting a broader equity rebound after the Treasury's announcement of increased buyback operations for longer-term debt.

18. Aug. 2026, 23:06 UTC

Quanterix Corp. shares are roughly flat in after-market hours. The stock remains near the lower end of its one-month range.

17. Aug. 2026, 20:01 UTC

News

Quanterix Corp shares are higher after Director William P. Donnelly's insider purchase of 72,245 shares at $2.93, despite a price target cut by Canaccord Genuity.

14. Aug. 2026, 23:01 UTC

Quanterix Corp shares are higher in after-market trading, despite no specific news. This follows mixed market sentiment after a decline in U.S. retail sales.

13. Aug. 2026, 20:02 UTC

Quanterix Corp shares are lower today amid a broader decline in the Life Sciences Tools & Services sub-sector, continuing a downward trend since Wednesday.

12. Aug. 2026, 23:01 UTC

Quanterix Corp. shares are trading roughly flat in after-market hours. The stock has seen a significant decline over the past month, remaining below its 20-day moving average.

11. Aug. 2026, 22:51 UTC

Quanterix Corp shares are lower in after-market hours, continuing a decline from Tuesday's close amid broader market pressure and rising crude oil prices.

10. Aug. 2026, 19:51 UTC

Event

Social Media

News

Quanterix Corp reported a wider second-quarter loss and lowered full-year revenue guidance, leading to a significant decline in shares amid investor concerns.

7. Aug. 2026, 19:16 UTC

Quanterix Corp shares are higher today, continuing a trend with three consecutive sessions of gains since Thursday. The stock is trading above its 20-day moving average.

5. Aug. 2026, 19:23 UTC

Quanterix Corp shares are higher, supported by a broader rise in the Life Sciences Tools & Services sector. The stock remains below its 20-day moving average.

3. Aug. 2026, 19:26 UTC

Quanterix Corp shares are higher today, tracking broader market gains amid rising confidence in tech stocks and falling energy prices.

31. Juli 2026, 19:46 UTC

Quanterix Corp shares are higher today, reflecting a modest gain since Thursday's close. The stock is near the lower end of its one-month range.

30. Juli 2026, 19:59 UTC

Quanterix Corp is trading higher amid a broader recovery in tech shares. The asset has shown notable volatility, pulling back from earlier session highs.

29. Juli 2026, 19:43 UTC

Macro Event

Quanterix Corp's shares are lower today amid broader market declines, reflecting heightened volatility following the Federal Reserve's decision to maintain interest rates.

28. Juli 2026, 20:06 UTC

Quanterix Corp shares are declining amid broader market weakness, with the Nikkei 225 dropping significantly due to concerns over AI spending and semiconductor competition.

27. Juli 2026, 16:06 UTC

Quanterix Corp shares are higher today, following a strong opening. No specific news was identified to explain the price movement.

24. Juli 2026, 19:53 UTC

Quanterix Corp shares are lower today, continuing a decline since Thursday amid broader market uncertainty from oil volatility and new U.S. tariffs.

22. Juli 2026, 19:36 UTC

Quanterix Corp shares are lower in Wednesday's session, continuing a decline since Tuesday's close amid rising crude oil prices and market concerns.

21. Juli 2026, 21:26 UTC

Quanterix Corp shares are higher in after-market hours, reflecting positive trading momentum. Broader market strength may be influencing sentiment following the close.

20. Juli 2026, 19:46 UTC

Quanterix Corp shares are higher today amid positive market sentiment and a notable rise in the Hang Seng 50 Index, despite no specific company news.

Peer-Vergleich

Kursveränderung

Quanterix Corp Prognose

Kursziel

By TipRanks

7.53% Vorteil

12-Monats-Prognose

Durchschnitt 3 USD 7.53%

Hoch 3 USD

Tief 3 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Quanterix Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Quanterix Corp – Dist abgegeben haben.

Stimmung

By Acuity

160 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.